CA998338A - Drug composition having antidiabetic activity - Google Patents

Drug composition having antidiabetic activity

Info

Publication number
CA998338A
CA998338A CA185,704A CA185704A CA998338A CA 998338 A CA998338 A CA 998338A CA 185704 A CA185704 A CA 185704A CA 998338 A CA998338 A CA 998338A
Authority
CA
Canada
Prior art keywords
drug composition
antidiabetic activity
antidiabetic
activity
drug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA185,704A
Other versions
CA185704S (en
Inventor
Hans-Hermann Schone
Adolf Mager
Rolf Geiger
Franz Enzmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Application granted granted Critical
Publication of CA998338A publication Critical patent/CA998338A/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/28Insulins
CA185,704A 1972-11-16 1973-11-13 Drug composition having antidiabetic activity Expired CA998338A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2256215A DE2256215C3 (en) 1972-11-16 1972-11-16 Insulin preparation containing crystalline insulin and amorphous desphenylalanine8 '-insulin

Publications (1)

Publication Number Publication Date
CA998338A true CA998338A (en) 1976-10-12

Family

ID=5861919

Family Applications (1)

Application Number Title Priority Date Filing Date
CA185,704A Expired CA998338A (en) 1972-11-16 1973-11-13 Drug composition having antidiabetic activity

Country Status (17)

Country Link
US (1) US3937820A (en)
JP (1) JPS4980223A (en)
AT (1) AT330345B (en)
BE (1) BE807417A (en)
CA (1) CA998338A (en)
DE (1) DE2256215C3 (en)
DK (1) DK136292C (en)
EG (1) EG11577A (en)
FR (1) FR2206933B1 (en)
GB (1) GB1450598A (en)
HU (1) HU170275B (en)
IE (1) IE38514B1 (en)
IL (1) IL43623A (en)
NL (1) NL7315379A (en)
NO (1) NO137845C (en)
SE (1) SE419824B (en)
ZA (1) ZA738743B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2459515C3 (en) * 1974-12-17 1982-02-11 Hoechst Ag, 6000 Frankfurt Medicinal preparations with an antidiabetic effect
DE3033127A1 (en) * 1980-09-03 1982-04-08 Hoechst Ag, 6000 Frankfurt NEW INSULIN ANALOG
DE3326472A1 (en) * 1983-07-22 1985-02-14 Hoechst Ag, 6230 Frankfurt NEW INSULIN DERIVATIVES, METHOD FOR THE PRODUCTION AND USE THEREOF AND PHARMACEUTICAL AGENTS FOR TREATING THE DIABETES MELLITUS
US5547929A (en) * 1994-09-12 1996-08-20 Eli Lilly And Company Insulin analog formulations
WO1997005166A1 (en) 1995-07-25 1997-02-13 Novartis Ag Transforming growth factor beta crystals

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3364116A (en) * 1964-11-02 1968-01-16 Squibb & Sons Inc Method of use of desalanino insulin compositions
EG10440A (en) * 1970-02-07 1977-09-30 Hoechst Ag Process for the preparation of des-phenylalamin b1-insuli

Also Published As

Publication number Publication date
EG11577A (en) 1977-09-30
IE38514L (en) 1974-05-16
ZA738743B (en) 1974-09-25
BE807417A (en) 1974-05-16
GB1450598A (en) 1976-09-22
AU6250573A (en) 1975-05-15
IL43623A0 (en) 1974-03-14
US3937820A (en) 1976-02-10
ATA961973A (en) 1975-09-15
JPS4980223A (en) 1974-08-02
NO137845C (en) 1978-05-10
IE38514B1 (en) 1978-03-29
SE419824B (en) 1981-08-31
HU170275B (en) 1977-05-28
DK136292C (en) 1978-02-20
IL43623A (en) 1976-12-31
DE2256215B2 (en) 1980-04-17
FR2206933B1 (en) 1977-10-28
DE2256215C3 (en) 1981-01-08
NL7315379A (en) 1974-05-20
NO137845B (en) 1978-01-30
FR2206933A1 (en) 1974-06-14
AT330345B (en) 1976-06-25
DK136292B (en) 1977-09-26
DE2256215A1 (en) 1974-05-30

Similar Documents

Publication Publication Date Title
CA1010781A (en) Insecticidal composition
AU472941B2 (en) Pharmaceutical compositions
CA973203A (en) Catalyst composition
AU475850B2 (en) Benzylidenesemicarbazide compounds having insecticidal activity
AU475599B2 (en) Pharmaceutical compositions
CA998338A (en) Drug composition having antidiabetic activity
AU476390B2 (en) Pharmaceutical composition
AU5915973A (en) Pharmaceutical compositions
AU486913B2 (en) Novel drug composition having antidlabetic activity
CA917630A (en) Catalyst composition
CA986412A (en) Iodophor-steroid pharmaceutical compositions
CA1006816A (en) Pharmaceutical compositions
CA890398A (en) Pesticidal composition
CA900357A (en) Pharmaceutical composition
AU478574B2 (en) Pharmaceutical composition
CA1010789A (en) Pharmaceutical composition having synergetic analgetic activity
AU480005B2 (en) Pharmaceutical composition having synergetic analgetic activity
AU6312673A (en) Pharmaceutical composition
CA910815A (en) Pharmacologically active composition
CA909677A (en) Therapeutically active composition
AU477526B2 (en) Insecticidal composition
CA897594A (en) Insecticidal composition
CA893087A (en) Insecticidal composition
CA902050A (en) Adamantylalkylaminoalkyl benzamides
CA893103A (en) Catalyst composition